<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ClinVarVariationRelease xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/ClinVar_VCV_2.0.xsd" ReleaseDate="2024-05-02">
<VariationArchive VariationID="654" VariationName="NM_000130.5(F5):c.6304C&gt;T (p.Arg2102Cys)" VariationType="single nucleotide variant" Accession="VCV000000654" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-04-15" DateCreated="2017-08-20" MostRecentSubmission="2019-09-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15693" VariationID="654">
      <GeneList>
        <Gene Symbol="F5" FullName="coagulation factor V" GeneID="2153" HGNC_ID="HGNC:3542" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169511951" stop="169586481" display_start="169511951" display_stop="169586481" Strand="-"/>
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169481191" stop="169555768" display_start="169481191" display_stop="169555768" Strand="-"/>
          </Location>
          <OMIM>612309</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000130.5(F5):c.6304C&gt;T (p.Arg2102Cys)</Name>
      <CanonicalSPDI>NC_000001.11:169518452:G:A</CanonicalSPDI>
      <VariantType>single nucleotide variant</VariantType>
      <Location>
        <CytogeneticLocation>1q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="169518453" stop="169518453" display_start="169518453" display_stop="169518453" variantLength="1" positionVCF="169518453" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="169487691" stop="169487691" display_start="169487691" display_stop="169487691" variantLength="1" positionVCF="169487691" referenceAlleleVCF="G" alternateAlleleVCF="A"/>
      </Location>
      <OtherNameList>
        <Name>F5, ARG2074CYS</Name>
        <Name>R2074C</Name>
      </OtherNameList>
      <ProteinChange>R2102C</ProteinChange>
      <HGVSlist>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="P12259" sequenceAccession="P12259" change="p.Arg2102Cys">
            <Expression>P12259:p.Arg2102Cys</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.169487691G&gt;A" Assembly="GRCh37">
            <Expression>NC_000001.10:g.169487691G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.169518453G&gt;A" Assembly="GRCh38">
            <Expression>NC_000001.11:g.169518453G&gt;A</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011806.1" sequenceAccession="NG_011806" sequenceVersion="1" change="g.73079C&gt;T">
            <Expression>NG_011806.1:g.73079C&gt;T</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000130.5" sequenceAccession="NM_000130" sequenceVersion="5" change="c.6304C&gt;T" MANESelect="true">
            <Expression>NM_000130.5:c.6304C&gt;T</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000121.2" sequenceAccession="NP_000121" sequenceVersion="2" change="p.Arg2102Cys">
            <Expression>NP_000121.2:p.Arg2102Cys</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001583" Type="missense variant" DB="SO"/>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_553" sequenceAccession="LRG_553">
            <Expression>LRG_553:g.73079C&gt;T</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_553t1" sequenceAccession="LRG_553t1">
            <Expression>LRG_553t1:c.6304C&gt;T</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_553p1" sequenceAccession="LRG_553p1" change="p.Arg2102Cys">
            <Expression>LRG_553p1:p.Arg2102Cys</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA251559" DB="ClinGen"/>
        <XRef ID="P12259#VAR_032701" DB="UniProtKB"/>
        <XRef Type="Allelic variant" ID="612309.0012" DB="OMIM"/>
        <XRef Type="rs" ID="118203910" DB="dbSNP"/>
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)"/>
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)"/>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD), exomes"/>
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000130.5(F5):c.6304C&gt;T (p.Arg2102Cys) AND Factor V deficiency" Accession="RCV000000688" Version="4">
        <ClassifiedConditionList TraitSetID="169">
          <ClassifiedCondition DB="MedGen" ID="C4317320">Factor V deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-01" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-02-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2017-08-20" MostRecentSubmission="2019-09-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12393490</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <DescriptionHistory Dated="2019-09-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="169" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1267" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Reduced coagulation factor V activity</ElementValue>
                <XRef ID="HP:0003225" DB="Human Phenotype Ontology"/>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Factor V deficiency</ElementValue>
                <XRef ID="Factor+V+Deficiency/2709" DB="Genetic Alliance"/>
                <XRef ID="HP:0003225" DB="Human Phenotype Ontology"/>
                <XRef ID="MONDO:0020586" DB="MONDO"/>
                <XRef ID="4320005" DB="SNOMED CT"/>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep vein thrombosis (DVT) is the most common VTE, with the legs being the most common site. Thrombosis in unusual locations is less common. Evidence suggests that heterozygosity for the Leiden variant has at most a modest effect on risk for recurrent thrombosis after initial treatment of a first VTE. It is unlikely that factor V Leiden thrombophilia (i.e., heterozygosity or homozygosity for the Leiden variant) is a major factor contributing to pregnancy loss and other adverse pregnancy outcomes (preeclampsia, fetal growth restriction, and placental abruption). The clinical expression of factor V Leiden thrombophilia is influenced by the following: The number of Leiden variants (heterozygotes have a slightly increased risk for venous thrombosis; homozygotes have a much greater thrombotic risk). Coexisting genetic thrombophilic disorders, which have a supra-additive effect on overall thrombotic risk. Acquired thrombophilic disorders: antiphospholipid antibody (APLA) syndrome, paroxysmal nocturnal hemoglobinuria, myeloproliferative disorders, and increased levels of clotting factors. Circumstantial risk factors including but not limited to pregnancy, central venous catheters, travel, combined oral contraceptive (COC) use and other combined contraceptives, oral hormone replacement therapy (HRT), selective estrogen receptor modulators (SERMs), obesity, leg injury, and advancing age.</Attribute>
                <XRef ID="NBK1368" DB="GeneReviews"/>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301542</ID>
                <ID Source="BookShelf">NBK1368</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2011">
                <ID Source="PubMed">21150787</ID>
              </Citation>
              <Citation Type="general" Abbrev="Retired, ACMG, 2001">
                <ID Source="pmc">3111091</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="ACMG, 2021">
                <ID Source="PubMed">33674767</ID>
              </Citation>
              <Citation Type="general" Abbrev="BSH, 2022">
                <ID Source="PubMed">35645034</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng158</URL>
                <CitationText>UK NICE Guideline NG158, Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, 2023</CitationText>
              </Citation>
              <XRef ID="326" DB="Orphanet"/>
              <XRef ID="C4317320" DB="MedGen"/>
              <XRef ID="MONDO:0020586" DB="MONDO"/>
              <XRef Type="primary" ID="HP:0003225" DB="Human Phenotype Ontology"/>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20838" SubmissionDate="2017-08-17" DateLastUpdated="2017-08-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612309.0012_FACTOR V DEFICIENCY" title="F5, ARG2074CYS_FACTOR V DEFICIENCY"/>
        <ClinVarAccession Accession="SCV000020838" DateUpdated="2017-08-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2003-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 22-year-old Italian woman in whom factor V deficiency (227400) was first diagnosed at the age of 10 years after abnormal coagulation screening tests were found preceding an operation for strabismus, Duga et al. (2003) identified a homozygous 6394C-T transition at in exon 23 of the F5 gene, resulting in an arg2074-to-cys (R2074C) change in the C2 domain of the protein. Functional studies showed that this substitution impaired both factor V secretion and its activity. The patient's menstruation was normal and her only bleeding symptom was easy bruising after minor trauma. Her parents, apparently nonconsanguineous, were asymptomatic and had factor V functional and antigen levels typical of heterozygotes.</Attribute>
              <Citation>
                <ID Source="PubMed">12393490</ID>
              </Citation>
              <XRef DB="OMIM" ID="227400" Type="MIM"/>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F5"/>
          </GeneList>
          <Name>F5, ARG2074CYS</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">ARG2074CYS</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612309.0012" Type="Allelic variant"/>
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">FACTOR V DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1769365" SubmissionDate="2019-03-28" DateLastUpdated="2019-09-29" DateCreated="2019-09-29">
        <ClinVarSubmissionID localKey="c.6304C&gt;T_227400" localKeyIsSubmitted="1" submittedAssembly="GRCh37"/>
        <ClinVarAccession Accession="SCV000899835" DateUpdated="2019-09-29" DateCreated="2019-09-29" Type="SCV" Version="1" SubmitterName="NIHR Bioresource Rare Diseases, University of Cambridge" OrgID="505998" OrganizationCategory="consortium" OrgAbbreviation="NIHR BR RD"/>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">31064749</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Targeted sequencing</TypePlatform>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1"/>
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">TGP0330</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="F5"/>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000130.4:c.6304C&gt;T</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="227400" Type="MIM"/>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <StudyName>ThromboGenomics</StudyName>
        <SubmissionNameList>
          <SubmissionName>ThromboGenomics</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20838" TraitType="Disease" MappingType="Name" MappingValue="FACTOR V DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C4317320" Name="Factor V deficiency"/>
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1769365" TraitType="Disease" MappingType="XRef" MappingValue="227400" MappingRef="OMIM">
        <MedGen CUI="C0015499" Name="Congenital factor V deficiency"/>
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>
</ClinVarVariationRelease>
